Our story.
R-Crio Stem Cells was founded in 2014 under the S/A corporate model, looking from the very beginning to the future prospects that this could provide. Conceived and developed by dentist and researcher Dr. José Ricardo Muniz Ferreira, from the beginning he sought to transform R-Crio into more than a mesenchymal stem cell bank, but rather to form a company that would become a cornerstone in the promotion of health through regenerative medicine and cell therapies in Brazil.
2014
Foundation and Assembly of the Laboratory
2015
Start of commercial operations
2016
Dissemination of the network of accredited professionals
2017
Beginning of relationship with Florida and Kennedy Space Center
Installation of equipment, regulatory, start of execution of strategic planning and construction of the laboratory in Campinas/SP.
Início dos credenciamentos e formatação da rede de dentistas credenciados e início da abertura dos canais de vendas.
Oxygenation of the network of accredited dentists and start of commercial advertising on social networks for greater reach.
Foundation and construction of the research and development laboratory within R-Crio. Beginning of research projects for tissue regeneration.
2018
Beginning of relationship with Florida and Kennedy Space Center
As a result of a lecture in Florida (USA), the partnership with KSCIA and the Michaelis Foundation for Global Education begins. First year of Science Days event for children with the institutions.
2019
Creation of handouts for educational program
Beginning of an educational approach to meet the emerging demand for content on the use of stem cells and biotechnology in health promotion. 7 educational booklets are developed.
2020
Início das pesquisas com PTAs e representação comercial
Diffusion of sales channels with national representatives with strategic partners. Start of research projects focusing on Advanced Cell Therapy Products (ATPs) recently regulated in early 2020.
2021
Beginning of development of a cell-based drug for immunomodulation
During the pandemic, R-Crio began to seek treatment for acute inflammatory processes, such as COVID-19. The conception of the idea and proof of concept for R-Imuno-Crio began.
2022
Franchise model configuration for commercial expansion
Início da criação dos modelos de franquias para profissionais de saúde incorporarem o serviço comercial, marketing, coleta e logística dentro de suas clínicas, utilizando a marca da R-Crio.
2023
Start of research to develop a product for cleft lip and palate
R-Crio strengthens its research and development arm with the start of studies for bone regeneration in children with cleft palate.
2024
Structuring the laboratory to become a biopharmaceutical company
Planning and structuring for delivery of cells as inputs for medicines or in-house production. Advancement of activities related to research, development and scientific partnerships.
2025
Strategic partnerships for stem cell-based drug formulation
Start of service provision and operation as a provider of stem cell-based therapeutic inputs for the development of new advanced cell therapy products.